Last reviewed · How we verify

NCT03765619

Postoperative Aspirin and Ankle Fracture Healing

Completed EARLY_PHASE1 Last updated 13 January 2025
What this trial tests

EARLY_PHASE1 trial testing Aspirin in Ankle Fractures in 500 participants. Completed in 26 November 2019.

Timeline
12 June 2019
Primary endpoint
26 November 2019
26 November 2019

Quick facts

Lead sponsorUniversity of Alabama at Birmingham
PhaseEARLY_PHASE1
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeprevention
Enrollment500
Start date12 June 2019
Primary completion26 November 2019
Estimated completion26 November 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Alabama at Birmingham

Who can join

Adults 18 to 110, any sex, with Ankle Fractures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to identify if postoperative aspirin use leads to a delay in fracture healing. NSAIDs have long been avoided in the management of fractures, due to the belief that they may impair fracture healing. As aspirin is frequently prescribed for long-term management of various medical conditions, it is worth understanding if continuing to take aspirin during the process of fracture healing has a clinically significant effect on the rate of fracture healing.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Aspirin

Trials testing the same drug.

Other recruiting trials for Ankle Fractures

Currently open trials in the same condition.

Other University of Alabama at Birmingham trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03765619.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing